New tool aims to predict which breast cancers might return
NCT ID NCT07484763
Summary
This study aims to create a prediction tool (called a nomogram) for a common type of early breast cancer (HR+/HER2-). Researchers will look back at the medical records of about 500 past patients to find patterns that predict whose cancer might return. The goal is to help doctors better decide which patients might benefit from more intensive treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER, HR+/HER2- EARLY-STAGE are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.